InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Sjogren Eric, Vice-Président Senior, Découverte de Médicaments. Officer active across 1 company, notably Calithera Biosciences, Inc.. In total, 8 disclosures have been published. Activity tracked since 27 October 2021. The latest transaction was disclosed on 21 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations8 total
4,794 shares@ US$0.491585.49% mcap8.2% of flowCommon StockSEC:0000899243-22-003135:0
4,794 shares@ US$0.491585.49% mcap16.5% of flowCommon StockSEC:0000899243-22-003135
18,077 shares@ US$0.660483.5% of flowCommon StockSEC:0000899243-22-001299
18,077 shares@ US$0.660441.8% of flowCommon StockSEC:0000899243-22-001299:0
30,000 shares0Common StockSEC:0000899243-21-043688:0
30,000 shares0Common StockSEC:0000899243-21-043688
90,000 shares0Common StockSEC:0000899243-21-042073
90,000 shares0Common StockSEC:0000899243-21-042073:0
8 of 8 declarations
About Sjogren Eric
Eric Sjogren is Senior Vice President, Drug Discovery at Calithera Biosciences, Inc. He oversees research and development initiatives, contributing to innovation and the creation of new treatments in the biopharmaceutical sector.
